We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Oral sodium clodronate for nonmetastatic prostate cancer--results of a randomized double-blind placebo-controlled trial: Medical Research Council PR04 (ISRCTN61384873).
- Authors
Mason, Malcolm D; Sydes, Matthew R; Glaholm, John; Langley, Ruth E; Huddart, Robert A; Sokal, Michael; Stott, Mark; Robinson, Anne C; James, Nicholas D; Parmar, Mahesh K B; Dearnaley, David P; Medical Research Council PR04 Collaborators
- Abstract
The most frequent site of metastases from prostate cancer is bone. Adjuvant bisphosphonate treatment improves outcomes of patients with bone metastasis-negative breast cancer, but the effects of bisphosphonates on bone metastases in prostate cancer are not known.
- Publication
Journal of the National Cancer Institute, 2007, Vol 99, Issue 10, p765
- ISSN
1460-2105
- Publication type
Journal Article
- DOI
10.1093/jnci/djk178